Xeris Biopharma Holdings, Inc. (XERS) earnings per share (EPS)

Earnings per share · fiscal 2024
-$0.37

Xeris Biopharma Holdings, Inc. (XERS) reported diluted earnings per share of -$0.37 in fiscal 2024 (the year ended December 31, 2024). In fiscal 2023 the figure was -$0.45. Figures as of 18 Nov 2026, 12:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2024
-$0.37
Highest on record
-$0.37fiscal 2024
Lowest on record
-$0.70fiscal 2022
Fiscal years on record
32022–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Xeris Biopharma Holdings, Inc. earnings per share (EPS), in more detail

Across the 3 fiscal years on record (2022–2024), the highest was -$0.37 in fiscal 2024 and the lowest -$0.70 in fiscal 2022.

History · 3 fiscal years

Earnings per share by fiscal year

Xeris Biopharma Holdings, Inc. earnings per share (EPS), year by year

Xeris Biopharma Holdings, Inc. (XERS) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2024-$0.37—
2023-$0.45—
2022-$0.70—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

More on XERS

Xeris Biopharma Holdings, Inc., figure by figure

Xeris Biopharma Holdings, Inc. (XERS) overview: price, valuation and scorecard

Xeris Biopharma Holdings, Inc. earnings per share (EPS): questions and answers

What is Xeris Biopharma Holdings, Inc.'s diluted earnings per share?

Xeris Biopharma Holdings, Inc. (XERS) reported diluted earnings per share of -$0.37 in fiscal 2024 (the year ended December 31, 2024). In fiscal 2023 the figure was -$0.45.

What are the highest and lowest diluted earnings per share figures on record for Xeris Biopharma Holdings, Inc.?

Across the 3 fiscal years on record (2022–2024), the highest was -$0.37 in fiscal 2024 and the lowest -$0.70 in fiscal 2022.

How is Xeris Biopharma Holdings, Inc.'s diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Xeris Biopharma Holdings, Inc. it is on record here for 3 fiscal years, 2022 to 2024.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Xeris Biopharma Holdings, Inc. (XERS) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/XERS/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.